Algun Ekinci-Polat

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

The efficacy and sustainability of a reduced risankizumab dose after achievement of low disease activity of psoriasis: a 24-week study.

The efficacy and sustainability of a reduced risankizumab dose after achievement of low disease activity of psoriasis: a 24-week study.

Journal: Anais brasileiros de dermatologia

Published: July 20, 2025

Treatment Failure in Scabies: Assessment of Risk Factors in a Multicenter Cross-Sectional Study.

Treatment Failure in Scabies: Assessment of Risk Factors in a Multicenter Cross-Sectional Study.

Journal: Dermatology practical & conceptual

Published: July 07, 2025

Two cases of cerebrovascular accidents following the induction dose of risankizumab.

Two cases of cerebrovascular accidents following the induction dose of risankizumab.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: September 15, 2024

A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis.

A Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Phase 2 Study Evaluating the Efficacy and Safety of GN-037 Cream in Patients with Mild-to-Moderate Plaque Psoriasis.

Journal: Dermatology and therapy

Published: September 13, 2024

Clinical Features and Natural Course of Hidradenitis Suppurativa in Turkey: A Multicenter Study.

Clinical Features and Natural Course of Hidradenitis Suppurativa in Turkey: A Multicenter Study.

Journal: Dermatology (Basel, Switzerland)

Published: May 03, 2023

Clinical course of psoriasis patients that discontinued biologics during the COVID-19 pandemic.

Clinical course of psoriasis patients that discontinued biologics during the COVID-19 pandemic.

Journal: Journal of cosmetic dermatology

Published: August 25, 2022

Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.

Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.

Journal: Journal of cosmetic dermatology

Published: May 27, 2022

Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.

Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.

Journal: Clinical and experimental dermatology

Published: May 22, 2021

Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey.

Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey.

Journal: Dermatologic therapy

Published: March 07, 2021

COVID-19-triggered sarcoidal granulomas mimicking scar sarcoidosis.

COVID-19-triggered sarcoidal granulomas mimicking scar sarcoidosis.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: January 22, 2021

The impact of COVID-19 pandemic on the management of patients with chronic urticaria: An observational two-center study from Turkey.

The impact of COVID-19 pandemic on the management of patients with chronic urticaria: An observational two-center study from Turkey.

Journal: Dermatologic therapy

Published: November 04, 2020

Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile.

Secukinumab and acitretin as a combination therapy for three clinical forms of severe psoriasis in multi-drug refractory patients: A case series of high efficacy and safety profile.

Journal: Dermatologic therapy

Published: October 27, 2020

Showing 1-12 of 35

Last Updated: 09/26/2026